Novelcare
Healthcare AI
Clinical-trial matching and patient recruitment
Seed
Novelcare, also known as SelectIQ, is a New York City-based healthcare technology company that uses artificial intelligence and electronic-health-record data to help physicians identify medically relevant, locally available clinical trials for their patients and help trial sites recruit participants. Its provider-facing Study Access platform integrates with electronic medical records and is marketed as free for most practices, with paid chart-review workflows for certain studies. The company is active in Y Combinator’s Winter 2023 batch and positions itself around reducing clinical-trial recruitment barriers and expanding patient access to investigational treatments.
Company Details
- Website
- novel.care
- Headquarters
- New York City, New York, USA; remote
- Founded
- 2022
- Funding
- $500K reported seed funding from Y Combinator; other sources report additional backing but do not pr
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring